US | Recovery Tracker sees strong end to summer
The US Recovery Tracker exited the summer on a bright note. It rose 0.7ppts to 96.7 during the two weeks ended September 3 – the highest reading since late July. Despite downside risks from the Delta variant, the health situation is stabilizing, mobility is nearing its pre-pandemic level, and household spending is steady.
What you will learn:
- Record equity valuations continue to underpin looser financial conditions, but Covid-related supply constraints are limiting production. Employment took a breather on weaker small business payrolls and increased UI benefits searches.
- Regional recoveries stabilized in early September. The South posted its first gain since early July as Delta variant infections fell from their peak.
- New Covid cases remain elevated, but hospitalizations are declining and inoculations are steady at 900k/day. We expect the wider adoption of vaccine mandates following full FDA approval of the Pfizer vaccine will support increasing uptake.
Tags:
Related Services
Post
APAC Key Themes 2026: Paybacks, policy offsets and trade
We believe APAC will remain the strongest global performer in 2026. However, the growth trajectory will likely be more uneven than in past cycles.
Find Out More
Post
Japan’s fiscal policy will remain loose, which increases risks to debt sustainabilit
We've changed our fiscal outlook for Japan in our December forecast round. We now expect the new government to set a primary deficit close to that of 2024, at 2%-3% of GDP for 2025-2027, instead of restoring a balanced budget by taking advantage of strong tax revenue. We assume higher bond yields will force the government to take measures to reduce the deficit from 2028.
Find Out More
